HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $668,882 | +99.1% | 17,510 | +129.2% | 0.20% | +17.9% |
| Q2 2022 | $336,000 | +122.5% | 7,639 | -25.9% | 0.17% | +110.0% |
| Q4 2018 | $151,000 | -53.7% | 10,313 | -42.6% | 0.08% | -43.7% |
| Q3 2018 | $326,000 | +34.2% | 17,965 | +44.5% | 0.14% | +140.7% |
| Q1 2018 | $243,000 | -68.7% | 12,429 | -67.6% | 0.06% | -74.1% |
| Q4 2017 | $777,000 | +164.3% | 38,345 | +126.9% | 0.23% | +174.7% |
| Q3 2017 | $294,000 | – | 16,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |